These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1854596)

  • 1. Monosialoganglioside GM1 in cerebral ischemia.
    Carolei A; Fieschi C; Bruno R; Toffano G
    Cerebrovasc Brain Metab Rev; 1991; 3(2):134-57. PubMed ID: 1854596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monosialoganglioside effects following cerebral ischemia: relationship with anti-neuronotoxic and pro-neuronotrophic effects.
    Lipartiti M; Seren MS; Lazzaro A; Koga T; Mazzari S; Facci L; Fusco M; Toffano G; Leon A
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):489-94. PubMed ID: 2130663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxic-ischemic damage and the neuroprotective effects of GM1 ganglioside.
    Leon A; Lipartiti M; Seren MS; Lazzaro A; Mazzari S; Koga T; Toffano G; Skaper SD
    Stroke; 1990 Nov; 21(11 Suppl):III95-7. PubMed ID: 2237992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monosialogangliosides, neuroprotection, and neuronal repair processes.
    Skaper SD; Leon A
    J Neurotrauma; 1992 May; 9 Suppl 2():S507-16. PubMed ID: 1613810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of monosialoganglioside GM1 in experimental models of ischemic brain damage.
    Lipartiti M; Lazzaro A; Zanoni R; Bonvento G; Mazzari S
    Ital J Neurol Sci; 1991 Jun; 12(3 Suppl 11):11-3. PubMed ID: 1757215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early effects of GM1 in experimental cerebral focal ischemia in rabbits.
    Bo P; Marchioni E; Soragna D; Savoldi F
    Boll Soc Ital Biol Sper; 1993 Nov; 69(11):705-10. PubMed ID: 8060600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monosialoganglioside GM1 reduces ischemia--reperfusion-induced injury in the rat retina.
    Weber M; Mohand-Said S; Hicks D; Dreyfus H; Sahel JA
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):267-73. PubMed ID: 8603830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GM1 ganglioside treatment of focal ischemia: a dose-response and microdialysis study.
    Simon RP; Chen J; Graham SH
    J Pharmacol Exp Ther; 1993 Apr; 265(1):24-9. PubMed ID: 8474009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of cerebral edema with GM1 ganglioside.
    Karpiak SE; Mahadik SP
    J Neurosci Res; 1984; 12(2-3):485-92. PubMed ID: 6094838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some functional consequences of chronic GM1 ganglioside administration in brain damaged rats.
    Stein DG
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):405-13. PubMed ID: 2130658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monosialoganglioside GM1 reduces NMDA neurotoxicity in neonatal rat brain.
    Lipartiti M; Lazzaro A; Zanoni R; Mazzari S; Toffano G; Leon A
    Exp Neurol; 1991 Sep; 113(3):301-5. PubMed ID: 1915720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of monosialoganglioside GM1 in LTP-induction in rat hippocampal slices.
    Li YX; Mei ZT
    Sci China B; 1994 May; 37(5):581-9. PubMed ID: 7917002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excitatory amino acid neurotoxicity in cultured retinal neurons: involvement of N-methyl-D-aspartate (NMDA) and non-NMDA receptors and effect of ganglioside GM1.
    Facci L; Leon A; Skaper SD
    J Neurosci Res; 1990 Oct; 27(2):202-10. PubMed ID: 2174980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment with monosialoganglioside GM1 protects the brain of fetal sheep against hypoxic-ischemic injury without causing systemic compromise.
    Tan WK; Williams CE; Gunn AJ; Mallard EC; Gluckman PD
    Pediatr Res; 1993 Jul; 34(1):18-22. PubMed ID: 8356012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intervention strategies for neonatal hypoxic-ischemic cerebral injury.
    Perlman JM
    Clin Ther; 2006 Sep; 28(9):1353-65. PubMed ID: 17062309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GM1 reduces infarct volume after focal cerebral ischemia.
    Lazzaro A; Seren MS; Koga T; Zanoni R; Schiavo N; Manev H
    Exp Neurol; 1994 Feb; 125(2):278-85. PubMed ID: 8313942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dorsal root ganglia and nerve growth factor: a model for understanding the mechanism of GM1 effects on neuronal repair.
    Leon A; Benvegnù D; Dal Toso R; Presti D; Facci L; Giorgi O; Toffano G
    J Neurosci Res; 1984; 12(2-3):277-87. PubMed ID: 6502753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The functional recovery of damaged brain: the effect of GM1 monosialoganglioside.
    Toffano G; Savoini G; Aporti F; Calzolari S; Consolazione A; Maura G; Marchi M; Raiteri M; Agnati LF
    J Neurosci Res; 1984; 12(2-3):397-408. PubMed ID: 6150119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GM1 ganglioside treatment after global ischemia protects changes in membrane fatty acids and properties of Na+, K+-ATPase and Mg2+-ATPase.
    Mahadik SP; Hawver DB; Hungund BL; Li YS; Karpiak SE
    J Neurosci Res; 1989 Nov; 24(3):402-12. PubMed ID: 2531806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review.
    Zhang W; Krafft PR; Wang T; Zhang JH; Li L; Tang J
    Cell Transplant; 2019 Jun; 28(6):657-661. PubMed ID: 30666888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.